報價延遲最少15分鐘:2025/07/04 07:13 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.56 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.48/-0.47
|
|
企業價值
217.86M
|
| 資產負債 |
|
每股賬面淨值
2.15
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
238.85M
|
|
每股收益
2.06
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/04 07:13 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment. |